Advancing precision oncology research.

Oncovera's research program leverages advances in omics and AI to obtain never-before-obtainable insights into aggressive prostate cancer — including earlier detection, therapy matching, and monitoring of progression to castrate-resistant disease.

A full Research page is coming soon. Contact us about collaborations, data partnerships, publications, and funded programs.